First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype

• Ana C. Glembotsky,
• Cecilia P. Marin Oyarzún,
• Geraldine De Luca,
• Christophe Marzac,
• Nathalie Auger,
• Nora P. Goette,
• Rosana F. Marta,
• Hana Raslova,
• Paula G. Heller

Affiliations

Ana C. Glembotsky

Instituto Lanari, Universidad de Buenos Aires, Hematologia Investigacion, Buenos Aires, Argentina;

Cecilia P. Marin Oyarzún

Instituto Lanari, Universidad de Buenos Aires, Hematologia Investigacion, Buenos Aires, Argentina;

Geraldine De Luca

Instituto Lanari, Universidad de Buenos Aires, Hematologia Investigacion, Buenos Aires, Argentina;

Christophe Marzac

INSERM UMR 1170, Gustave Roussy, Universite' Paris-Saclay, Villejuif, France;

Nathalie Auger

Department of Tumor Genetics, Gustave Roussy Cancer Campus, Universite Paris-Saclay, Villejuif, France;

Nora P. Goette

Instituto Lanari, Universidad de Buenos Aires, Hematologia Investigacion, Buenos Aires, Argentina;

Rosana F. Marta

Instituto Lanari, Universidad de Buenos Aires, Hematologia Investigacion, Buenos Aires, Argentina;

Hana Raslova

INSERM UMR 1170, Gustave Roussy, Villejuif, France.

Paula G. Heller

Instituto Lanari, Universidad de Buenos Aires, Hematologia Investigacion, Buenos Aires, Argentina;